Strand Therapeutics
Boston, US · 18 known investors
Find your way into Strand Therapeutics
861 people in our graph share verified history with the Strand Therapeutics team — schools, employers, funds. One of them is your warm intro.
Kike Mirallesunlockedknows Jake Becraft · together at Starlight Ventures (overlapped)
×4knows the team · via MIT
knows the team · via University of Illinois Urbana-Champaign
×6knows the team · via Massachusetts Institute of Technology
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
Founders & leadership
TK
Tasuku KitadainCo-founderTasuku Kitada has worked as a scientist, biotech analyst, and biotech executive with experience in multiple countries including the U.S., EU, and Japan. He is co-founder and executive officer at Strand Therapeutics, which develops programmable mRNA therapies for cancer and other diseases.
JB
Jacob BecraftinCo-founderJacob Becraft holds a PhD in Biological Engineering and Synthetic Biology from MIT and a BS in Chemical and Biomolecular Engineering from the University of Illinois at Urbana-Champaign. As co-founder and CEO of Strand Therapeutics, he leads development of programmable mRNA therapies; his research at MIT focused on synthetic biology platforms for mRNA engineering.
SK
Samta KunduinExecutive
Board
JK
Jeb KeiperBoard director
AA
Ala AlenaziBoard director
PE
Pegah EbrahimiBoard director
JB
Jory BellBoard director
Investors · 18
JIC Venture Growth InvestmentsTokyo
KinnevikStockholm
Playground GlobalPalo Alto · $1M – $20M
Amgen VenturesreportedThousand Oaks · $1M – $3M
ANRIreportedTokyo · $497K – $78M
FPVreportedJackson · $100K – $5M
ICONIQreported · 2 sourcesSan Francisco
LG Technology Venturesreported · 2 sourcesSanta Clara
Third Rock VenturesreportedBoston · $100K – $5Mvia Jeb Keiper · board
Also in the syndicate · 9
Alderline GroupAmgenEli LillyFPV VenturesGradiant Corp.JIC-VGIPlaygroundleadRegeneronRegeneron Ventures
Funding
SEC filings, press & company announcements$319.1M disclosed across 4 of 6 rounds · 2019–2025
- $153MSeries BAug 2025 · 3 sources
Kinnevik (lead), Alderline Group, Amgen, Eli Lilly, FPV Ventures, Gradiant Corp., JIC-VGI, LG Technology Ventures, Playground Global, Regeneron
Source ↗ - Undisclosed amountSeries A1Nov 2022Source ↗
▶$108.1MraisedMar 2026 · 10 investors · BiotechnologyRule 506(b)
▶$108.1MraisedMar 2026 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeb KeiperDirector
- Ala AlenaziDirector
- Pegah EbrahimiDirector
- Tasuku KitadaExecutive Officer, Director, Promoter
- Samta KunduExecutive Officer
- Jory BellDirector
- Jacob BecraftExecutive Officer, Director, Promoter
- Offering amount
- $120.1M
- Amount sold
- $108.1M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$52.1MraisedJul 2021 · 13 investors · BiotechnologyRule 506(b)
▶$52.1MraisedJul 2021 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tasuku KitadaExecutive Officer, Director, Promoter
- Jacob BecraftExecutive Officer, Director, Promoter
- Samta Jacob KunduExecutive Officer
- Jory BellDirector
- Offering amount
- $52.1M
- Amount sold
- $52.1M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.9MraisedJun 2019 · 11 investors · BiotechnologyRule 506(b)
▶$5.9MraisedJun 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tasuku KitadaExecutive Officer, Director, Promoter
- Jory BellDirector
- Jacob BecraftExecutive Officer, Director, Promoter
- Offering amount
- $5.9M
- Amount sold
- $5.9M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Strand Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Strand Therapeutics do?
- Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
- Who founded Strand Therapeutics?
- Strand Therapeutics was founded by Tasuku Kitada, Jacob Becraft.
- Who are Strand Therapeutics's investors?
- Strand Therapeutics's investors include JIC Venture Growth Investments, Kinnevik, Playground Global, Amgen Ventures, ANRI, FPV, ICONIQ, LG Technology Ventures and 1 more.
- How much funding has Strand Therapeutics raised?
- Strand Therapeutics has disclosed $319.1M raised across 4 of its 6 known rounds.
- Where is Strand Therapeutics headquartered?
- Strand Therapeutics is headquartered in Boston, US.